Search results for "Statins"
Telmisartan does not improve walking performance in PAD
A randomized double-blind trial compared the angiotensin-receptor blocker with placebo in patients with peripheral artery disease (PAD) and found no difference in six-minute walk distance over six months.
https://immattersacp.org/weekly/archives/2022/10/11/2.htm
11 Oct 2022
Pinpoint patients' top priorities
An approach to decision making in older adults with multiple chronic conditions begins with identifying the patient's health priorities before deciding which treatments to continue, stop, or start to align care with these individual goals.
https://immattersacp.org/archives/2021/06/pinpoint-patients-top-priorities.htm
1 Jun 2021
Calculating risk for cholesterol drugs
Differing guidelines and a new class of drugs may cause uncertainty on the part of patients and practitioners.
https://immattersacp.org/archives/2015/11/cholesterol.htm
1 Nov 2015
New cholesterol guideline focuses on statin intensity, not LDL
A new cholesterol guideline focuses on the intensity of statin therapy, the 10-year risk or lifetime risk, and the balancing of those benefits with the risks and side effects of the medicine. Also, the therapeutic response should be considered when managing hyperlipidemia.
https://immattersacp.org/archives/2014/06/cholesterol.htm
1 Jun 2014
Cardiovascular medications underused in Hispanic/Latino patients with PAD
Efforts to improve peripheral artery disease (PAD) treatment in Hispanic/Latino populations are needed, including improved access to health care and more guideline-adherent treatment, according to the authors of a recent study.
https://immattersacp.org/weekly/archives/2020/08/11/5.htm
11 Aug 2020
Adding colchicine after MI may reduce cardiovascular events
While a trial found that low-dose colchicine reduced cardiovascular events after myocardial infarction (MI) significantly more than placebo, there are unresolved questions about inflammation as a therapeutic target, an accompanying editorial noted.
https://immattersacp.org/weekly/archives/2019/11/26/1.htm
26 Nov 2019
Warning about mixing protease inhibitors with statins
This regulatory update includes a warning on combining protease inhibitors and statins, approval of an orphan drug, and steps the FDA is taking to increase the supply of cancer drugs.
https://immattersacp.org/archives/2012/05/fda.htm
1 May 2012
Lack of access to PCSK9 inhibitors associated with cardiovascular events
Risk for myocardial infarction, unstable angina, acute ischemic heart disease, ischemic stroke, percutaneous coronary intervention, coronary artery bypass graft, and cardiac arrest was higher in patients whose prescription for a PCSK9 inhibitor was denied or abandoned.
https://immattersacp.org/weekly/archives/2019/07/30/2.htm
30 Jul 2019
MKSAP Quiz: Routine office visit for patient with HIV
A 44-year-old man is evaluated in the office during a routine visit. Medical history is significant for HIV diagnosed at age 25 years, hypertension, and hyperlipidemia. He is a current smoker. Following a physical exam, lab tests, and electrocardiogram, what factors will result in underestimation of the risk for atherosclerotic cardiovascular disease in this patient?
https://immattersacp.org/weekly/archives/2018/12/18/3.htm
18 Dec 2018
Why internists should care about lipoprotein(a)
Lipoprotein(a) can be a significant risk factor for heart disease and requires consideration when developing a plan of care, especially in the highest risk patients.
https://immattersacp.org/archives/2020/05/why-internists-should-care-about-lipoproteina.htm
1 May 2020